Home Newsfeeds HeartCore Enterprises Q2 EPS $(0.09) Down From $0.03 YoY

HeartCore Enterprises Q2 EPS $(0.09) Down From $0.03 YoY

HeartCore Enterprises (NASDAQ:HTCR) reported quarterly losses of $(0.09) per share. This is a 400 percent decrease over earnings of $0.03 per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

HeartCore Enterprises (NASDAQ:HTCR) reported quarterly losses of $(0.09) per share. This is a 400 percent decrease over earnings of $0.03 per share from the same period last year.

Earnings

Recap: Neoleukin Therapeutics Q2 Earnings

By Benzinga Insights

August 9, 4:54 PM

Neoleukin Therapeutics (NASDAQ:NLTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

NLTX

Timber Pharmaceuticals Announces 1-For-50 Reverse Stock Split

By Benzinga Newsdesk

November 8, 1:12 PM

Timber Pharmaceuticals, Inc. (NYSE:TMBR) ("Timber" or the "Company"), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare

TMBR

SNDL To Acquire Four Dutch Love Cannabis Dispensaries

By Vuk Zdinjak

March 28, 7:59 AM

SNDL Inc. (NASDAQ: SNDL) has entered into an agreement with Lightbox Enterprises Ltd. to acquire four cannabis retail stores operating under the Dutch Love Cannabis banner.

NVACF

4 Tesla Analysts On EV Giant’s Margin Strategy: ‘Stormy Weather For Now, Sunny In Spring Next Year’

By Chris Katje

April 20, 10:38 AM

Electric vehicle giant Tesla Inc (NASDAQ: TSLA) reported first quarter financial results after the market close Wednesday.

TSLA

HeartCore Enterprises Q2 EPS $(0.09) Down From $0.03 YoY

Related Posts

Recap: Neoleukin Therapeutics Q2 Earnings

Timber Pharmaceuticals Announces 1-For-50 Reverse Stock Split

SNDL To Acquire Four Dutch Love Cannabis Dispensaries

4 Tesla Analysts On EV Giant’s Margin Strategy: ‘Stormy Weather For Now, Sunny In Spring Next Year’